merck & co. news - Search News

Merck, Modifi

Merck sets sights on brain cancer with $30M Modifi acquisition

Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset designed to take on the tough-to-treat brain cancer glioblastoma.

MarketWatch · 13h

Merck Buys Yale Cancer-Therapy Spinout Modifi Biosciences

Merck & Co. has acquired Modifi Biosciences, a developer of cancer therapies that was spun out of Yale University, in a deal potentially worth more than $1 billion.

Business Insider · 11h

Merck acquires Modifi Biosciences for $30M upfront

Modifi Biosciences announced that the company has been acquired by Merck (MRK). Under the terms of the agreement Merck, through a subsidiary,

Reuters on MSN · 14h

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of the deal, the U.S.

MarketWatch · 7h

Modifi Biosciences Acquired by Merck

Modifi Biosciences, Inc. ("Modifi Biosciences"), a leader in the development of direct DNA modification enabled cancer therapeutics, today announced that the company has been acquired by Merck, known as MSD outside of the United States and Canada.

13hon MSN

Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?

We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are ...

BioPharma Dive11h

Merck acquires cancer drug startup; Elevidys ex-US sales rise

Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...

6hon MSN

CDC Panel Favors Wider Use of Pfizer, Merck Pneumococcal Shots

A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and ...

BioWorld1d

Modifi acquired by Merck in $1.3B deal

Spun out of Yale University in 2021, it published data on DNA in Science in July 2022, and now it’s being acquired by Merck ...

Hartford Business11h

Merck acquires Yale-spinout Modifi Bio in $1.3B deal

Modifi Biosciences, a New Haven startup biotech that focuses on developing cancer therapies, has been acquired by ...

Zacks Research Predicts Lower Earnings for Merck & Co., Inc.

Zacks Research lowered their Q3 2024 earnings estimates for Merck & Co., Inc. in a report issued on Monday, October 21st.

FierceBiotech2d

Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks, setting stage for pivotal program

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

11h

Merck & Company (MRK) Receives a Buy from Jefferies

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...

Yahoo Finance1d

Merck & Co., Inc. (MRK)

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical study evaluating the investigational combination of islatravir and ...

The Journal1d

Merck Animal Health introduces SENSEHUB Dairy Youngstock

Merck Animal Health, a division of Merck & Co., Inc., Rahway, New Jersey, has introduced SENSEHUB Dairy Youngstock, the ...

Barchart on MSN6d

Here's What to Expect From Merck & Co.'s Next Earnings Report

Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results